Roivant Sciences Ltd [ROIV] stock is trading at $11.82, up 2.87%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ROIV shares have gain 1.55% over the last week, with a monthly amount glided 1.72%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Roivant Sciences Ltd [NASDAQ: ROIV] stock has seen the most recent analyst activity on February 15, 2024, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $17. Previously, Piper Sandler started tracking the stock with Overweight rating on January 05, 2024, and set its price target to $20. On December 12, 2023, Deutsche Bank initiated with a Buy rating and assigned a price target of $14 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $17 on October 17, 2023. BofA Securities initiated its recommendation with a Neutral and recommended $10.50 as its price target on June 08, 2023. JP Morgan started tracking with a Overweight rating for this stock on October 27, 2022, and assigned it a price target of $7. In a note dated May 23, 2022, SVB Leerink initiated an Outperform rating and provided a target price of $6 on this stock.
Roivant Sciences Ltd [ROIV] stock has fluctuated between $8.56 and $13.06 over the past year. Currently, Wall Street analysts expect the stock to reach $16.21 within the next 12 months. Roivant Sciences Ltd [NASDAQ: ROIV] shares were valued at $11.82 at the most recent close of the market. An investor can expect a potential return of 37.14% based on the average ROIV price forecast.
Analyzing the ROIV fundamentals
Roivant Sciences Ltd [NASDAQ:ROIV] reported sales of 125.68M for the trailing twelve months, which represents a drop of -87.94%. Gross Profit Margin for this corporation currently stands at 0.89% with Operating Profit Margin at 34.48%, Pretax Profit Margin comes in at 37.82%, and Net Profit Margin reading is 38.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.78, Equity is 0.83 and Total Capital is 0.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.64 points at the first support level, and at 11.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.99, and for the 2nd resistance point, it is at 12.15.
Ratios To Look Out For
For context, Roivant Sciences Ltd’s Current Ratio is 10.43. Further, the Quick Ratio stands at 10.43, while the Cash Ratio is 3.54. Considering the valuation of this stock, the price to sales ratio is 68.46, the price to book ratio is 1.68 and price to earnings (TTM) ratio is 2.09.
Transactions by insiders
Recent insider trading involved Venker Eric, Officer, that happened on Nov 20 ’24 when 100000.0 shares were purchased. President & COO, Venker Eric completed a deal on Oct 21 ’24 to sell 100000.0 shares. Meanwhile, Officer Venker Eric bought 100000.0 shares on Oct 21 ’24.
